Impact Biomedical Inc. SEC filings IBO
Impact Biomedical Inc. has 146 filings in SEC EDGAR's recent list, going back to Feb 12, 2021. Its latest annual report, Form 10-K, was filed on Mar 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2026 | Nov 2, 2026 |
| 425 | Filing | Nov 3, 2026 | — |
| DEFM14A | Filing | Oct 27, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 9, 2026 | Sep 23, 2026 |
| 4 | Insider transaction | Sep 24, 2026 | Sep 22, 2026 |
| 425 | Filing | Sep 17, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 17, 2026 | Sep 16, 2026 |
| 425 | Filing | Sep 15, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2026 | Sep 14, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 144 | Notice of proposed sale | Apr 29, 2026 | — |
| S-8 POS | Filing | Apr 22, 2026 | — |
| S-8 POS | Filing | Apr 6, 2026 | — |
| 4 | Insider transaction | Mar 30, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| 10-K | Annual report | Mar 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 4, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | May 22, 2025 |
| DEF 14C | Information statement | Dec 30, 2025 | Dec 30, 2025 |
| PRE 14C | Filing | Dec 11, 2025 | Dec 11, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 6, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Other events
|
Oct 27, 2025 | Oct 24, 2025 |
| DEF 14A | Proxy statement | Sep 22, 2025 | Sep 22, 2025 |
| DEF 14C | Information statement | Sep 9, 2025 | Sep 9, 2025 |
| PRE 14C | Filing | Aug 25, 2025 | Aug 25, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| DEF 14C | Information statement | Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 28, 2025 | Jul 21, 2025 |
| PRE 14C | Filing | Jul 16, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 23, 2025 | Jun 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 7, 2025 | Apr 4, 2025 |
| 4 | Insider transaction | Apr 7, 2025 | Apr 3, 2025 |
| 4 | Insider transaction | Apr 4, 2025 | Apr 2, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 4, 2025 | — |
| 8-K |
Current report
Material agreement
|
Apr 3, 2025 | Apr 3, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Apr 2, 2025 | — |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 21, 2025 |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 28, 2025 | Mar 24, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Dec 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 13, 2025 | Mar 11, 2025 |
| UPLOAD | Letter from the SEC | Mar 10, 2025 | — |
| CORRESP | Letter to the SEC | Mar 7, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 29, 2025 | Jan 29, 2025 |
| S-8 | Employee stock plan registration | Jan 24, 2025 | — |
| CORRESP | Letter to the SEC | Jan 10, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2024 | — |
| 4 | Insider transaction | Dec 9, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 26, 2024 |
| 4 | Insider transaction | Nov 22, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 8, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Sep 19, 2024 | Sep 18, 2024 |
| 4 | Insider transaction | Sep 18, 2024 | Sep 16, 2024 |
| 3/A | Filing | Sep 18, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 17, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 17, 2024 | Sep 16, 2024 |
| 424B4 | Prospectus | Sep 17, 2024 | — |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| EFFECT | Filing | Sep 13, 2024 | — |
| CORRESP | Letter to the SEC | Sep 9, 2024 | — |
| CORRESP | Letter to the SEC | Sep 9, 2024 | — |
| CORRESP | Letter to the SEC | Sep 5, 2024 | — |
| CORRESP | Letter to the SEC | Sep 5, 2024 | — |
| CORRESP | Letter to the SEC | Sep 3, 2024 | — |
| CORRESP | Letter to the SEC | Sep 3, 2024 | — |
| S-1/A | Amended registration statement | Aug 27, 2024 | — |
| 8-A12B/A | Filing | Aug 23, 2024 | — |
| S-1/A | Amended registration statement | Aug 20, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| CORRESP | Letter to the SEC | Aug 12, 2024 | — |
| CORRESP | Letter to the SEC | Aug 12, 2024 | — |
| S-1/A | Amended registration statement | Aug 9, 2024 | — |
| CERT | Nyse american certification | Aug 9, 2024 | — |
| CORRESP | Letter to the SEC | Aug 8, 2024 | — |
| CORRESP | Letter to the SEC | Aug 8, 2024 | — |
| 8-A12B | Filing | Aug 8, 2024 | — |
| S-1/A | Amended registration statement | Jun 11, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jun 7, 2024 | Jun 6, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| S-1/A | Amended registration statement | Feb 28, 2024 | — |
| 10-K | Annual report | Feb 20, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement
|
Jan 22, 2024 | Jan 18, 2024 |
| S-1/A | Amended registration statement | Nov 21, 2023 | — |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Nov 6, 2023 | Oct 31, 2023 |
| S-1/A | Amended registration statement | Nov 1, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2023 | — |
| S-1 | Registration statement | Oct 17, 2023 | — |
| 10-Q | Quarterly report | Oct 5, 2023 | Jun 30, 2023 |
| EFFECT | Filing | Aug 4, 2023 | — |
| CORRESP | Letter to the SEC | Aug 2, 2023 | — |
| S-1/A | Amended registration statement | Aug 1, 2023 | — |
| CORRESP | Letter to the SEC | Jul 24, 2023 | — |
| S-1/A | Amended registration statement | Jul 24, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 13, 2023 | — |
| CORRESP | Letter to the SEC | Jun 30, 2023 | — |
| S-1/A | Amended registration statement | Jun 30, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2023 | — |
| CORRESP | Letter to the SEC | Jun 21, 2023 | — |
| S-1/A | Amended registration statement | Jun 21, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2023 | — |
| S-1/A | Amended registration statement | Jun 2, 2023 | — |
| CORRESP | Letter to the SEC | Jun 2, 2023 | — |
| UPLOAD | Letter from the SEC | May 25, 2023 | — |
| S-1/A | Amended registration statement | May 15, 2023 | — |
| CORRESP | Letter to the SEC | Jan 31, 2023 | — |
| S-1/A | Amended registration statement | Jan 31, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 20, 2023 | — |
| CORRESP | Letter to the SEC | Jan 9, 2023 | — |
| S-1/A | Amended registration statement | Jan 9, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2023 | — |
| CORRESP | Letter to the SEC | Dec 7, 2022 | — |
| S-1/A | Amended registration statement | Dec 7, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2022 | — |
| CORRESP | Letter to the SEC | Aug 24, 2022 | — |
| S-1/A | Amended registration statement | Aug 24, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2022 | — |
| S-1/A | Amended registration statement | Aug 2, 2022 | — |
| CORRESP | Letter to the SEC | Aug 2, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2022 | — |
| S-1/A | Amended registration statement | Jul 11, 2022 | — |
| S-1/A | Amended registration statement | Jun 24, 2022 | — |
| CORRESP | Letter to the SEC | Jun 24, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Sep 29, 2021 | — |
| S-1/A | Amended registration statement | Sep 29, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 24, 2021 | — |
| S-1 | Registration statement | Feb 12, 2021 | — |
Showing 146 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IBO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- West Henrietta, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1834105
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.